DE68924237T2 - Verfahren zur Herstellung von Verbindungen zur Behandlung der gutartigen Prostatahypertrophie. - Google Patents

Verfahren zur Herstellung von Verbindungen zur Behandlung der gutartigen Prostatahypertrophie.

Info

Publication number
DE68924237T2
DE68924237T2 DE68924237T DE68924237T DE68924237T2 DE 68924237 T2 DE68924237 T2 DE 68924237T2 DE 68924237 T DE68924237 T DE 68924237T DE 68924237 T DE68924237 T DE 68924237T DE 68924237 T2 DE68924237 T2 DE 68924237T2
Authority
DE
Germany
Prior art keywords
formula
compounds
preparation
treatment
benign prostate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68924237T
Other languages
English (en)
Other versions
DE68924237D1 (de
Inventor
Apurba Bhattacharya
Ulf H Dolling
Joseph S Amato
John M Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of DE68924237D1 publication Critical patent/DE68924237D1/de
Publication of DE68924237T2 publication Critical patent/DE68924237T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
DE68924237T 1988-10-31 1989-10-26 Verfahren zur Herstellung von Verbindungen zur Behandlung der gutartigen Prostatahypertrophie. Expired - Fee Related DE68924237T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/264,652 US5237061A (en) 1988-10-31 1988-10-31 Methods of synthesizing benign prostatic hypertropic agents and their intermediates

Publications (2)

Publication Number Publication Date
DE68924237D1 DE68924237D1 (de) 1995-10-19
DE68924237T2 true DE68924237T2 (de) 1996-04-25

Family

ID=23007023

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68924237T Expired - Fee Related DE68924237T2 (de) 1988-10-31 1989-10-26 Verfahren zur Herstellung von Verbindungen zur Behandlung der gutartigen Prostatahypertrophie.

Country Status (11)

Country Link
US (1) US5237061A (de)
EP (1) EP0367502B1 (de)
JP (1) JPH0714959B2 (de)
AT (1) ATE127809T1 (de)
CA (1) CA1326013C (de)
CY (1) CY2078B1 (de)
DE (1) DE68924237T2 (de)
DK (1) DK170734B1 (de)
ES (1) ES2078909T3 (de)
HK (1) HK1002707A1 (de)
IE (1) IE67802B1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5061801A (en) * 1990-09-24 1991-10-29 Merck & Co., Inc. Intermediate for making 3-oxo-4-aza-androst-1-ene 17β-ketones
CA2050824A1 (en) * 1990-09-24 1992-03-25 John M. Williams Process for making 3-oxo-4-aza-androst-1-ene 17-.beta.-ketones
US5304562A (en) * 1991-10-09 1994-04-19 Ciba-Geigy Corporation 17β-substituted Aza-androstane derivatives
HU212459B (en) * 1992-10-02 1996-06-28 Richter Gedeon Vegyeszet Process for producing new 17-beta-substituted 4-aza-androstane-derivatives and pharmaceutical compositions containing them
US5468860A (en) * 1992-11-19 1995-11-21 Merck & Co., Inc. New finasteride processes
TW369521B (en) * 1993-09-17 1999-09-11 Smithkline Beecham Corp Androstenone derivative
US5470976A (en) * 1994-09-07 1995-11-28 Merck & Co., Inc. Process for the stereoselective reduction of steroid enelactams
US5541322A (en) * 1994-10-14 1996-07-30 Glaxo Wellcome Inc. Synthesis of 6-azaandrostenones
US5656613A (en) * 1995-01-04 1997-08-12 Merck & Co., Inc. Treatment of hyperandrogenic conditions
GB9727522D0 (en) * 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Process for preparing carboxamido-4-azasteroids
ES2153789B1 (es) * 1999-07-05 2001-10-16 Raga Consultores S L Procedimiento para la obtencion de 178-(n-terc-butlcarbamoil)-3-ona-4-aza-esteroides
US6182013B1 (en) * 1999-07-23 2001-01-30 Schlumberger Technology Corporation Methods and apparatus for dynamically estimating the location of an oil-water interface in a petroleum reservoir
EP1322663A1 (de) * 2000-09-07 2003-07-02 Dr. Reddy's Laboratories Ltd. Neue polymorphe form von 17-beta-(n-ter.butyl carbamoyl)-4-aza-5- g(a)-androst-1-en-3-one und ein verfahren zur ihrer herstellung
CZ2003679A3 (cs) * 2000-09-07 2004-02-18 Dr. Reddy´S Laboratories Ltd. Nová polymorfní forma 17beta-(N-terc-butylkarbamoyl)-4-aza-5alfa-androst-1-en-3-on a způsob její přípravy
AU2001269911B2 (en) 2000-09-07 2006-09-21 Dr. Reddy's Laboratories Ltd. Novel polymorphic form of 17-beta-(n-ter.butyl carbamoyl)-4-aza-5-alpha-androst-1-en-3-one and a process for preparing it
US6645974B2 (en) 2001-07-31 2003-11-11 Merck & Co., Inc. Androgen receptor modulators and methods for use thereof
US7149749B2 (en) * 2002-06-03 2006-12-12 International Business Machines Corporation Method of inserting and deleting leaves in tree table structures
ES2206065B1 (es) 2002-10-31 2005-08-16 Ragactives, S.L. Procedimiento para la obtencion de la forma polimorfica i de finasterida.

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4602099A (en) * 1973-04-02 1986-07-22 Merrell Dow Pharmaceuticals Inc. Antirhinovirus agents
SE7701916L (sv) * 1976-04-27 1977-10-28 Sandoz Ag Organiska foreningar, deras framstellning och anvendning
US4197308A (en) * 1976-11-12 1980-04-08 The Upjohn Company Analgesic N-(2-heterocyclic-amino cycloaliphatic) benzamides
US4377584A (en) * 1978-04-13 1983-03-22 Merck & Co., Inc. 4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors
US4179453A (en) * 1978-04-13 1979-12-18 Merck & Co., Inc. Process for preparing 17β-carboxy-5-androsten-3-ones
US4220775A (en) * 1979-03-15 1980-09-02 Merck & Co., Inc. Preparation of 4-aza-17-substituted-5α-androstan-3-ones useful as 5α-reductase inhibitors
US4460509A (en) * 1981-08-19 1984-07-17 Beth Israel Medical Center Chemical synthesis
US4760071A (en) * 1984-02-27 1988-07-26 Merck & Co., Inc. 17β-N-monosubstituted carbamoyl-4-aza-5α-androst-1-en-3-ones which are active as testosterone 5α-reductase inhibitors
IL74365A (en) * 1984-02-27 1990-07-26 Merck & Co Inc 17beta-(n-t.-butylcarbamoyl)-4-aza-5alpha-androst-1-en-3-one and pharmaceutical compositions containing it
US4859681A (en) * 1984-02-27 1989-08-22 Merck & Co., Inc. 17 α-Acyl-4-aza-5a-androst-1-en-3-ones as 5 alpha-reductase inhibitors
FR2571727B1 (fr) * 1984-10-16 1987-06-12 Roussel Uclaf Nouveaux produits steroides comportant, en position 23, un radical dihydro oxazolyle, leur procede de preparation, leur application a la preparation de produits de la serie des 20 cetopregnanes et intermediaires de cette application
DE3780778T2 (de) * 1986-11-20 1993-01-14 Merck & Co Inc Topisches arzneimittel enthaltend 17-beta-methoxy-carbonyl-4-methyl-4-aza-5-alpha-androst-1-en-3-one.
US4845104A (en) * 1986-11-20 1989-07-04 Merck & Co., Inc. Oxidized analogs of 17β-N-monosubstituted-carbamoyl-4-aza-5-α-androstan-3-ones
NZ225100A (en) * 1987-06-29 1991-09-25 Merck & Co Inc Reaction of steroids (including 4-azasteroids) with a silylating agent in the presence of a quinone to introduce a delta' double bond and silylated intermediates

Also Published As

Publication number Publication date
US5237061A (en) 1993-08-17
DK539589D0 (da) 1989-10-30
CA1326013C (en) 1994-01-11
HK1002707A1 (en) 1998-09-11
DK170734B1 (da) 1995-12-27
CY2078B1 (en) 1998-10-16
JPH02172999A (ja) 1990-07-04
DK539589A (da) 1990-05-01
EP0367502B1 (de) 1995-09-13
JPH0714959B2 (ja) 1995-02-22
DE68924237D1 (de) 1995-10-19
EP0367502A1 (de) 1990-05-09
IE893483L (en) 1990-04-30
ATE127809T1 (de) 1995-09-15
IE67802B1 (en) 1996-05-01
ES2078909T3 (es) 1996-01-01

Similar Documents

Publication Publication Date Title
DE68924237T2 (de) Verfahren zur Herstellung von Verbindungen zur Behandlung der gutartigen Prostatahypertrophie.
DE69106977D1 (de) Verfahren zur Herstellung von Nitrilen.
DE69029334D1 (de) Verfahren zur Herstellung von Alkoxyiminoacetamid-Derivaten und ein Zwischenproduckt dafür
DK633088A (da) Kollagenaseinhibitorer
DE59509910D1 (de) Verfahren zur Herstellung von Alkylhydrogenchlorsilanen
ATE113594T1 (de) Verfahren zur herstellung von sulfonylharnstoff- derivaten.
DE69100196T2 (de) Verfahren zur Herstellung von Benzylaminen.
ATE45720T1 (de) Verfahren zur herstellung von 2(hydroxyalkyl)acrylverbindungen.
ATE36318T1 (de) Verfahren zur herstellung von azetidinderivaten und zwischenprodukte.
DE69937988D1 (de) Verfahren zur herstellung von 3-cephemderivaten
ATE30718T1 (de) Herstellung von 1-benzyl azetidin-3-ol und von dem entsprechenden halid acid.
DE69733716D1 (de) Verfahren zur herstellung von imidazolderivaten
ATE25680T1 (de) Verfahren zur herstellung von 4-amino-5-dialkoxy- methylpyrimidinderivaten.
DE69130995D1 (de) Verfahren zur Herstellung von 5-Arylhydantoin
ATE75730T1 (de) Verfahren zur herstellung substituierter guanylthioharnstoffe.
DE69024114T2 (de) Verfahren zur Herstellung von Penemen
ATE59375T1 (de) Verfahren zur herstellung von polyenaldehyden.
ATE116288T1 (de) Verfahren zur herstellung von sulfonylisocyanaten.
ATE77373T1 (de) Verfahren zur herstellung von chinolinsaeurederivaten.
DE69022660T2 (de) Verfahren zur Herstellung von Carbamatderivaten des Lankacidines.
DE69303577D1 (de) Verfahren zur Halognierung von Aromatischen Verbindungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee